Galena Pharma Oy

Galena Pharma Oy is a Finnish company specializing in contract manufacturing and packaging services for pharmaceuticals and health products, leveraging its extensive expertise in product development and market introduction. Established in 1996 and headquartered in Kuopio, Finland, Galena Pharma Oy focuses on offering contract manufacturing solutions for the pharmaceutical industry. The company was involved in a significant business change in January 2021 when Intera Partners acquired a majority stake, although the financial details were not disclosed. The current CEO is Alexej Von Bagh, who has been instrumental in guiding the company through these transitions.

Galena Pharma Oy specializes in providing comprehensive contract manufacturing and packaging services for pharmaceuticals and health products. Their core offerings include the production of medicinal products, medical devices, and health-related goods, catering to diverse clients, including pharmaceutical companies and health product brands. The company's expertise streamlines the product development lifecycle from initial concept to market delivery, ensuring adherence to regulatory standards while serving clients across Finland and Europe. In the most recent year, Galena Pharma Oy reported a revenue of USD 4,137,302.

60, with an EBITDA of USD 899,261. 40 for the year 2023. The company generates revenue through B2B partnerships with pharmaceutical companies and health product manufacturers, typically establishing long-term contracts characterized by project-based pricing structures. Looking ahead, Galena Pharma Oy aims to expand its product offerings and explore new markets.

The company is actively designing new products tailored to emerging health needs, with plans for launches in various European markets by the end of 2023. The majority stake acquisition by Intera Partners in January 2021 is anticipated to facilitate these expansion efforts, providing the financial backing necessary for scaling operations and enhancing capabilities.